Biorestorative Therapies Inc. engages in developing therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders including obesity and diabetes. Its initial investigational therapeutic product being called BRTX-100 focuses on treating damage by autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process., The company was founded on June 13, 1997 and is headquartered in Melville, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Broadrick Dale | 10% Owner | Sep 15 | Buy | 1.66 | 10,000 | 16,600 | 327,573 | Sep 18 09:20 AM | ALSTODT LANCE | President, CEO, COB | Sep 15 | Buy | 1.70 | 2,200 | 3,740 | 189,505 | Sep 18 09:17 AM | Broadrick Dale | 10% Owner | Sep 14 | Buy | 1.54 | 10,000 | 15,400 | 317,573 | Sep 18 09:20 AM | ALSTODT LANCE | President, CEO, COB | Sep 13 | Buy | 1.53 | 800 | 1,226 | 188,105 | Sep 13 05:00 PM | Broadrick Dale | 10% Owner | Sep 07 | Buy | 1.91 | 1,000 | 1,910 | 317,972 | Sep 14 04:08 PM | Broadrick Dale | 10% Owner | Sep 07 | Buy | 1.81 | 1,000 | 1,810 | 307,573 | Sep 14 04:08 PM | ALSTODT LANCE | President, CEO, COB | Sep 06 | Buy | 1.96 | 2,887 | 5,659 | 187,305 | Sep 06 05:53 PM | Silva Francisco | VP of Research and Development | Aug 31 | Buy | 2.22 | 4,954 | 10,998 | 164,644 | Aug 31 01:54 PM | Broadrick Dale | 10% Owner | Jul 28 | Buy | 2.89 | 500 | 1,445 | 306,573 | Sep 14 04:08 PM | Broadrick Dale | 10% Owner | Jul 27 | Buy | 2.80 | 1,000 | 2,800 | 306,073 | Jul 28 11:17 AM | ALSTODT LANCE | President, CEO, COB | Jul 25 | Buy | 2.44 | 4,200 | 10,248 | 184,418 | Jul 25 05:56 PM | Silva Francisco | VP of Research and Development | Mar 31 | Buy | 3.56 | 747 | 2,659 | 159,690 | Apr 04 07:00 AM | Broadrick Dale | 10% Owner | Feb 22 | Buy | 2.86 | 6,000 | 17,150 | 305,073 | Mar 03 04:11 PM | ALSTODT LANCE | President, CEO, COB | Feb 01 | Buy | 3.10 | 400 | 1,241 | 187,321 | Feb 02 02:49 PM | ALSTODT LANCE | President, CEO, COB | Jan 27 | Buy | 3.01 | 200 | 602 | 186,921 | Jan 30 09:33 AM | ALSTODT LANCE | President, CEO, COB | Jan 20 | Buy | 3.13 | 200 | 627 | 186,721 | Jan 24 12:27 PM | ALSTODT LANCE | President, CEO, COB | Jan 18 | Buy | 3.11 | 400 | 1,244 | 186,521 | Jan 20 08:19 AM | ALSTODT LANCE | President, CEO, COB | Jan 09 | Buy | 3.08 | 100 | 308 | 186,121 | Jan 10 06:06 PM | ALSTODT LANCE | President, CEO, COB | Dec 23 | Buy | 3.01 | 300 | 903 | 186,021 | Dec 28 08:22 AM | ALSTODT LANCE | President, CEO, COB | Dec 07 | Buy | 2.99 | 1,800 | 5,375 | 185,721 | Dec 07 06:04 PM | Broadrick Dale | 10% Owner | Nov 30 | Buy | 2.77 | 200 | 555 | 299,073 | Mar 03 04:11 PM | Silva Francisco | VP of Research and Development | Nov 21 | Buy | 2.62 | 943 | 2,467 | 166,046 | Nov 21 05:14 PM | ALSTODT LANCE | President, CEO, COB | Nov 18 | Buy | 2.88 | 1,000 | 2,876 | 183,921 | Nov 21 07:49 AM | Silva Francisco | VP of Research and Development | Oct 12 | Buy | 3.39 | 725 | 2,457 | 165,103 | Oct 12 02:01 PM | Silva Francisco | VP of Research and Development | Oct 11 | Buy | 3.69 | 806 | 2,973 | 164,378 | Oct 12 08:54 AM |
|